The NHS will provide the monoclonal antibody Crysvita at 20 specialist centres a...
Eton has acquired the rights in the US to Amglidia for neonatal diabetes mellitu...
Tiragolumab missed the chance to prove a survival benefit in SKYSCRAPER-01 addin...
Gilead and Aelix first teamed up in 2018 for a clinical research collaboration a...
Roche has signed an agreement for the acquisition of Poseida Therapeutics in a d...
The Food and Drug Administration (FDA) has approved Shorla Oncology‘s IMKELDI fo...
PCI Pharma Services is a winner in the Innovation and Business Expansion categor...
This latest raise is intended to accelerate the development of the biotech’s fou...
The biopharmaceutical industry is being called to take its sustainability effort...
Arrowhead has entered a worldwide licensing and partnership agreement with Sarep...
A bispecific antibody has emerged in the HER2 arena, exhibiting a different prof...
Hailed as the first oral peptide designed to selectively block IL-23, Johnson & ...
The US FDA has approved BridgeBio Pharma’s Attruby (acoramidis) for treating adu...
Amneal Pharmaceuticals has submitted another NDA for its DHE prefilled syringe a...
Zai Lab and Pfizer have entered a strategic collaboration for the commercialisat...
Several pharmaceutical companies are advancing dry powder inhalers (DPIs) for re...
